Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Advances in Respiratory Medicine
MENU
Shortcuts Submit an article Guide for Authors Ahead Of Print Author statement Editorial Policy and Information for Authors Reviewers 2020

open access

Vol 72, No 11-12 (2004)
Case report
Published online: 2008-02-18
Submitted: 2013-02-22
View PDF (polish) Download PDF file
Get Citation

Mycobacterium kansasii infection in chronic thromboembolic pulmonary hypertension (CTEPH), report of two cases.

Monika Szturmowicz, Anna Fijałkowska, Ewa Rowińska-Zakrzewska, Leila Youssef Khalil, Anna Piwek, Paweł Kuca, Lucyna Opoka, Ewa Augustynowicz-Kopeć, Zofia Zwolska, Adam Torbicki
Pneumonol Alergol Pol 2004;72(11-12):523-529.

open access

Vol 72, No 11-12 (2004)
CASE REPORTS
Published online: 2008-02-18
Submitted: 2013-02-22

Abstract

Mycobacterium kansasii infection leads to significant morbidity both in immunocompetent and immunocompromised patients. 7 subtypes of M. Kansasii were identified so far. Subtypes 1 and 2 are known to be pathogenic to humans, subtypes 3-7 are commonly isolated from the environment and rarely cause disease. In the present study we report on two cases of chronic thromboembolic pulmonary hypertension (CTEPH) complicated by M. kansasii infection. Disease was recognized according to ATS criteria. Resolution of lesions was observed in both patients in the course of antituberculous treatment. These are to our knowledge the first recognized cases of M. Kansasii infection in CTEPH. Chronic hypoxemia with impaired lung metabolism could be responsible for susceptibility to infection with nonpathogenic subtype 4 of M. Kansasii.
Pneumonol. Alergol. Pol. 2004, 72, 523:529

Abstract

Mycobacterium kansasii infection leads to significant morbidity both in immunocompetent and immunocompromised patients. 7 subtypes of M. Kansasii were identified so far. Subtypes 1 and 2 are known to be pathogenic to humans, subtypes 3-7 are commonly isolated from the environment and rarely cause disease. In the present study we report on two cases of chronic thromboembolic pulmonary hypertension (CTEPH) complicated by M. kansasii infection. Disease was recognized according to ATS criteria. Resolution of lesions was observed in both patients in the course of antituberculous treatment. These are to our knowledge the first recognized cases of M. Kansasii infection in CTEPH. Chronic hypoxemia with impaired lung metabolism could be responsible for susceptibility to infection with nonpathogenic subtype 4 of M. Kansasii.
Pneumonol. Alergol. Pol. 2004, 72, 523:529

Full Text:

View PDF (polish) Download PDF file
Get Citation

Keywords

pulmonary hypertension; nontuberculous mycobacteria; pulmonary embolism

About this article
Title

Mycobacterium kansasii infection in chronic thromboembolic pulmonary hypertension (CTEPH), report of two cases.

Journal

Advances in Respiratory Medicine

Issue

Vol 72, No 11-12 (2004)

Article type

Case report

Pages

523-529

Published online

2008-02-18

Bibliographic record

Pneumonol Alergol Pol 2004;72(11-12):523-529.

Keywords

pulmonary hypertension
nontuberculous mycobacteria
pulmonary embolism

Authors

Monika Szturmowicz
Anna Fijałkowska
Ewa Rowińska-Zakrzewska
Leila Youssef Khalil
Anna Piwek
Paweł Kuca
Lucyna Opoka
Ewa Augustynowicz-Kopeć
Zofia Zwolska
Adam Torbicki

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl